SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: VLAD who wrote (16876)12/12/1998 3:18:00 PM
From: John M. Gelnieau  Read Replies (2) | Respond to of 23519
 
All I know is that this company needs to make its own news and it is a total failure at doing so. The only hope we have is that the interim CFO keeps the cost squeeze on until scripts pick up.

I still say that scripts in U.S. are remarkable given the fact there is no damn sales force focused on selling MUSE. A good partnership or focused sales strategy should move scripts up relatively quickly.

Of course, then will VVUS report 15 - 20 monthly script increases or will we have to find out from someone's neigbor who knows someone at the plant who gets a tip that production is up?

Just venting a little I guess. At this point EU news is out and trying so sort of holding back strategy makes no sense to me. MHO!



To: VLAD who wrote (16876)12/12/1998 7:52:00 PM
From: 777 Captain  Read Replies (2) | Respond to of 23519
 
VLAD: Another theory: VVUS in no longer calling the shots. That would explain a LOT of things. Regards.